ALUMIS INC.

ALMS

ALUMIS INC.

ALMS

Insider Sentiment (TTM):

Last Purchase:2026-01-09Last Sale:-Shares Purchased (TTM):3,490,111Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:94,965,978Shares Outstanding:125,050,645Institutional Ownership Pct.:75.94%

Earnings Market Reaction:

Filing Date:2026-05-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Voting Common Stock	0	6	0	0	0	7	0	-
Nonvoting Common Stock	0	6	0	0	0	7	0	-
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	64	90	65	152	129	170	213	155
Restricted Cash Current	0	0	-	0	-	-	-	0
Marketable Securities Current	-	219	312	335	80	119	148	54
Prepaid Expense And Other Assets Current	-	-	-	-	4	-	-	-
Debt Securities Available For Sale Excluding Accru…	459	-	-	-	-	-	-	-
Assets Current	532	318	393	518	226	306	377	225
Restricted Cash Noncurrent	1	1	1	1	1	1	1	1
Debt Securities Available For Sale Excluding Accru…	47	-	-	-	-	-	-	-
Property Plant And Equipment Net	18	18	19	20	20	21	21	22
Indefinite Lived Intangible Assets Excluding Goodw…	51	51	51	51	-	-	-	-
Operating Lease Right Of Use Asset	16	17	18	18	14	13	13	13
Other Assets Noncurrent	7	6	6	2	0	0	0	4
Assets	672	412	488	611	261	341	413	265
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	12	10	5	15	7	10	6	9
Contract With Customer Liability Current	6	1	-	-	-	-	-	-
Operating Lease Liability Current	4	5	4	4	3	2	1	2
Liabilities Current	71	73	65	86	60	51	34	33
Operating Lease Liability Noncurrent	31	32	33	35	29	29	30	30
Contract With Customer Liability Noncurrent	-	3	2	3	3	-	-	-
Deferred Income Tax Liabilities Net	2	2	2	2	-	-	-	-
Other Liabilities Noncurrent	0	0	0	0	-	-	-	-
Liabilities	105	111	103	126	93	81	64	65
Temporary Equity Carrying Amount Attributable To P…	-	-	-	-	-	-	-	639
Common Stock Value	-	-	-	-	-	-	-	0
Stockholders Equity
Additional Paid In Capital	1,562	1,203	1,193	1,183	926	919	912	32
Accumulated Other Comprehensive Income Loss Net Of…	-0	0	0	0	-0	0	0	-0
Retained Earnings Accumulated Deficit	-995	-902	-809	-698	-758	-659	-564	-471
Stockholders Equity	567	301	385	485	168	260	348	-439
Temporary Equity Par Or Stated Value Per Share	-	-	-	-	-	0	0	0
Liabilities And Stockholders Equity	672	412	488	611	261	341	413	265
Common Class A	-	-	-	-	-	-	-	29
Common Class B	-	-	-	-	-	-	-	7
Temporary Equity Shares Authorized	-	-	-	-	-	0	0	203
Temporary Equity Shares Issued	-	-	-	-	-	0	0	168
Temporary Equity Shares Outstanding	-	0	-	-	-	0	0	168
Temporary Equity Liquidation Preference	-	-	-	-	-	0	0	630
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	-
Preferred Stock Shares Authorized	50	50	50	50	50	50	50	-
Preferred Stock Shares Issued	0	0	0	0	0	0	0	-
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-22.61%	7.59%	-	-	-	-	-	-	-	-	-	-
2025	-20.40%	-24.61%	-8.43%	2.04%	-9.05%	7.47%	110.61%	69.60%	364.20%	-9.18%	-6.78%	-24.90%
2024	-	-	-	-4.63%	-22.33%	-9.81%	-16.74%	-21.83%	-30.80%	48.28%	15.10%	-17.85%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Liquidity Ratios
Current Ratio	7.51	4.34	6.01	6.05	3.73	6.01	11.26	6.73
Quick Ratio	7.51	4.34	6.01	6.05	3.67	6.01	11.26	6.73
Working Capital	461.50M	244.91M	327.87M	431.98M	165.08M	255.28M	343.83M	191.44M
Leverage & Debt
Debt to Equity	0.18	0.37	0.27	0.26	0.55	0.31	0.18	-0.15
Debt Ratio	0.16	0.27	0.21	0.21	0.36	0.24	0.16	0.24
Efficiency & Turnover
Asset Turnover TTM	0.02	0.06	0.05	0.05	0.07	-	-	-
Per Share Metrics
Diluted EPS TTM	-1.90	-2.86	-2.83	-3.62	-7.24	-	-	-
Free Cash Flow Per Share TTM	-3.02	-4.35	-3.59	-4.54	-6.21	-	-	-
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	-	-	-
Margin Metrics
Operating Profit Margin TTM	-5,364.02%	-1,886.92%	-2,276.45%	-2,426.73%	-2,313.43%	-	-	-
Net Profit Margin TTM	-2,825.70%	-1,011.75%	-1,333.58%	-1,383.03%	-2,261.18%	-	-	-
Growth Metrics
Net Revenue Growth (1Y)	-51.68%	-	-	-	-	-	-	-
Net Income Growth (1Y)	-39.62%	-	-	-	-	-	-	-
EPS Growth (1Y)	-73.79%	-	-	-	-	-	-	-
Valuation Metrics
P/E TTM	-11.60	-3.41	-1.41	-0.83	-0.85	-	-	-
P/B TTM	4.86	2.75	1.08	0.47	1.98	0.86	1.65	-1.48
P/S TTM	327.88	34.51	18.78	11.44	19.17	-	-	-
Market Cap	2.75B	829.89M	415.40M	229.43M	333.28M	222.77M	574.07M	650.64M
Enterprise Value	2.69B	738.84M	348.77M	75.93M	203.58M	52.14M	359.63M	494.40M
Calculated Values
Free Cash Flow TTM	-377.03M	-370.18M	-373.40M	-347.04M	-337.20M	-	-	-
Net Debt	-65.27M	-91.05M	-66.63M	-153.50M	-129.71M	-170.63M	-214.44M	-156.25M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-01-09Purchase

Owner: Akkaraju, Srinivas

Title: -

Shares: 588,235

Price/Share: $17.00

Value: $9,999,995.00

Shares Owned: 1,853,488

Relationship: Director

Ownership: Indirect

2026-01-08Purchase

Owner: Foresite, Labs Fund I, L.…

Title: -

Shares: 411,764

Price/Share: $17.00

Value: $6,999,988.00

Shares Owned: 5,702,536

Relationship: TenPercentOwner

Ownership: Indirect

2026-01-08Purchase

Owner: Foresite, Labs, Llc, Fore…

Title: -

Shares: 411,764

Price/Share: $17.00

Value: $6,999,988.00

Shares Owned: 5,702,536

Relationship: TenPercentOwner

Ownership: Indirect

2026-01-08Purchase

Owner: Tananbaum, James B.

Title: -

Shares: 411,764

Price/Share: $17.00

Value: $6,999,988.00

Shares Owned: 5,702,536

Relationship: Director,TenPercentOwner

Ownership: Indirect

2025-12-05Purchase

Owner: Akkaraju, Srinivas

Title: -

Shares: 186,377

Price/Share: $9.90

Value: $1,845,132.30

Shares Owned: 1,265,253

Relationship: Director

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-01-09	Akkaraju, Srinivas	Director	-	Indirect	Purchase	588,235	17.00	$9,999,995.00	1,853,488	4
2026-01-08	Foresite, Labs Fund I, L.…	TenPercentOwner	-	Indirect	Purchase	411,764	17.00	$6,999,988.00	5,702,536	4
2026-01-08	Foresite, Labs, Llc, Fore…	TenPercentOwner	-	Indirect	Purchase	411,764	17.00	$6,999,988.00	5,702,536	4
2026-01-08	Tananbaum, James B.	Director,TenPercentOwner	-	Indirect	Purchase	411,764	17.00	$6,999,988.00	5,702,536	4
2025-12-05	Akkaraju, Srinivas	Director	-	Indirect	Purchase	186,377	9.90	$1,845,132.30	1,265,253	4
2025-12-04	Akkaraju, Srinivas	Director	-	Indirect	Purchase	66,027	8.18	$540,100.86	1,078,876	4
2025-12-01	Akkaraju, Srinivas	Director	-	Indirect	Purchase	86,350	7.46	$644,171.00	816,849	4
2025-11-21	Foresite, Labs Affiliates…	TenPercentOwner	-	Indirect	Purchase	72,212	7.38	$532,924.56	2,614,215	4
2025-11-21	Tananbaum, James B.	Director,TenPercentOwner	-	Indirect	Purchase	72,212	7.38	$532,924.56	2,614,215	4
2025-11-21	Foresite, Labs Fund I, L.…	TenPercentOwner	-	Indirect	Purchase	72,212	7.38	$532,924.56	2,614,215	4
2025-11-20	Akkaraju, Srinivas	Director	-	Indirect	Purchase	125,743	7.20	$905,349.60	643,260	4
2025-11-19	Foresite, Labs Affiliates…	TenPercentOwner	-	Indirect	Purchase	190,500	6.56	$1,249,680.00	2,542,003	4
2025-11-19	Akkaraju, Srinivas	Director	-	Indirect	Purchase	137,772	6.56	$903,784.32	517,517	4
2025-11-19	Foresite, Capital Managem…	TenPercentOwner	-	Indirect	Purchase	190,500	6.56	$1,249,680.00	2,542,003	4
2025-11-19	Tananbaum, James B.	Director,TenPercentOwner	-	Indirect	Purchase	190,500	6.56	$1,249,680.00	2,542,003	4
2025-11-13	Akkaraju, Srinivas	Director	-	Indirect	Purchase	276,179	5.25	$1,449,939.75	276,179	4
2025-05-06	Tananbaum, James B.	Director,TenPercentOwner	-	Indirect	Purchase	20,000	4.34	$86,800.00	4,247,670	4
2025-05-06	Foresite, Labs Affiliates…	TenPercentOwner	-	Indirect	Purchase	20,000	4.34	$86,800.00	4,247,670	4
2025-05-06	Foresite, Labs Management…	TenPercentOwner	-	Indirect	Purchase	20,000	4.34	$86,800.00	4,247,670	4
2025-05-05	Akkaraju, Srinivas	Director	-	Indirect	Purchase	160,370	4.92	$789,020.40	3,586,788	4
2025-04-02	Colowick, Alan	Director	-	Indirect	Purchase	2,300	7.49	$17,227.00	18,404	4
2025-04-01	Babler, Martin	Director,Officer	President, CEO and Chairman	Indirect	Purchase	15,650	6.44	$100,786.00	106,454	4
2024-07-01	Foresite, Labs Affiliates…	TenPercentOwner	-	Indirect	Purchase	2,500,000	16.00	$40,000,000.00	5,584,889	4
2024-07-01	Tananbaum, James B.	Director,TenPercentOwner	-	Indirect	Purchase	2,500,000	16.00	$40,000,000.00	5,584,889	4
2024-07-01	Foresite, Capital Opportu…	TenPercentOwner	-	Indirect	Purchase	2,500,000	16.00	$40,000,000.00	5,584,889	4
2024-07-01	Akkaraju, Srinivas	Director	-	Indirect	Purchase	1,562,500	16.00	$25,000,000.00	3,266,498	4/A
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

75.94%

Inst. Shares: 94,965,978

Shares Outstanding: 125,050,645

2025-12-31

92.82%

Inst. Shares: 78,928,322

Shares Outstanding: 85,029,624

2025-09-30

74.84%

Inst. Shares: 77,914,644

Shares Outstanding: 104,109,243

2025-06-30

102.00%

Inst. Shares: 78,007,037

Shares Outstanding: 76,477,144

2025-03-31

148.01%

Inst. Shares: 80,342,864

Shares Outstanding: 54,280,264

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	94,965,978	125,050,645	75.94%
2025-12-31	78,928,322	85,029,624	92.82%
2025-09-30	77,914,644	104,109,243	74.84%
2025-06-30	78,007,037	76,477,144	102.00%
2025-03-31	80,342,864	54,280,264	148.01%
2024-12-31	80,458,968	28,341,866	283.89%
2024-09-30	69,926,622	53,752,223	130.09%
2024-06-30	57,107,802	48,920,440	116.74%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

ALUMIS INC. (ALMS) — SEC Financial Statements & Analysis

ALUMIS INC. (ALMS) is a pharmaceutical preparations company, incorporated in DE. ALUMIS INC. trades on ALMS: Nasdaq as: ALMS. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), ALUMIS INC. reported a -51.68% year-over-year revenue growth, a Debt-to-Equity ratio of 0.18x, a Price-to-Sales (P/S) ratio of 327.88x (TTM), a Price-to-Book (P/B) ratio of 4.86 (TTM), at a market cap of $2.75B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -51.68%
Debt To Equity: 0.18x
P/S TTM: 327.88x
P/B TTM: 4.86
Market Cap: $2.75B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ALUMIS INC. in?

ALUMIS INC. (ALMS) operates in the Pharmaceutical Preparations industry.

What is ALMS's market cap?

ALUMIS INC. (ALMS) has a market capitalization of $2.75B as of 2026-03-31.

What exchange does ALMS trade on?

ALUMIS INC. (ALMS) trades on the ALMS: Nasdaq.

Where is ALUMIS INC. incorporated?

ALUMIS INC. is incorporated in DE.

ALUMIS INC. (ALMS) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.